SAKAR — Sakar Healthcare Income Statement
0.000.00%
Last trade - 00:00
- IN₹7.73bn
- IN₹8.50bn
- IN₹1.33bn
- 63
- 14
- 64
- 42
R2019 March 31st | 2020 March 31st | 2021 March 31st | R2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 682 | 830 | 947 | 1,282 | 1,334 |
Cost of Revenue | |||||
Gross Profit | 328 | 399 | 436 | 509 | 574 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 574 | 705 | 802 | 1,085 | 1,152 |
Operating Profit | 108 | 125 | 145 | 197 | 182 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 92.3 | 122 | 132 | 190 | 169 |
Provision for Income Taxes | |||||
Net Income After Taxes | 66.9 | 96.2 | 107 | 152 | 128 |
Net Income Before Extraordinary Items | |||||
Net Income | 66.9 | 96.2 | 107 | 152 | 128 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 66.9 | 96.2 | 107 | 152 | 128 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.93 | 6.43 | 7.09 | 9.96 | 6.75 |